Autologous bone marrow transplantation in late first complete remission improves outcome in acute myelogenous leukemia

Leukemia

Volumn 10, Issue 3, 1996, Pages 402-409

  Miggiano, M C ^a   Gherlinzoni, F ^a,d   Rosti, G ^a   Bandini, G ^a   Visani, G ^a   Fiacchini, M ^a   Ricci, P ^a   Testoni, N ^a   Motta, M R ^a   Geromin, A ^b   Rizzi, S ^a   Belardinelli, A ^c   Mangianti, S ^a   Manfroi, S ^a   Tura, S ^a  

^a Istituto di Ematologia 'Seragnoli'   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c Ctro Trasfusionale Policlin S O   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Acute myelogenous leukemia; Autologous bone marrow transplantation; Bu Cy protocol; First complete remission

Indexed keywords

AMSACRINE; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; IDARUBICIN; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEVER; HEART ARREST; HEMORRHAGIC CYSTITIS; HUMAN; LEUKEMIA REMISSION; LIVER VENOOCCLUSIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 15844387872     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Bishop JF, Lowenthal RM, Jochua D, Matthews JP, Todd D, Cobcroft R, Whiteside MG, Kronemberg H, Ma D, Dodds A, Herrmann R, Szer J, Wolf NN, Young G. Etoposide in acute non lymphocytic leukemia. Blood 1990; 75: 27-32.
2. Buchner T, Hiddemann W, Blasius S. Adult AML; the role of chemotherapy intensity and duration. Two studies of the AML cooperative group. Haematol Blood Transfus 1990; 33: 261-266.
3. Rees JKH. Chemotherapy of the leukemias. In: Freireich EJ (ed). New Approaches to the Treatment of Leukemia. ESO monograph. Springer-Verlag: Berlin, 1990, pp 5-77.
4. Bandini G, Zuffa E, Rosti G, Battista R, D'Emilio E, Leoni F, Ciolli S, Barbui T, Bassan R, Todeschini G, Perona G, Scapoli GL. Mangoni L, Morra E, Di Prisco U, Visani G, Tura S. Long-term outcome of adults with acute myelogenous leukemia: results of a prospective, randomized study of chemotherapy with a minimal follow-up of 7 years. Br J Haematol 1991; 77: 486-490.
5. Ljungman P, de Witte T, Verdonck L, Gahrton G, Freycon F, Gravett P, McCann S, Morgentern HG, Nikoskelainen J, Powles R, Proctor SJ, Volin L, Zwaan F, Gratwohl A. Bone marrow transplantation for acute myeloblastic leukemia: an EMBT Leukemia Working Party prospective analysis from HLA-typing. Br J Haematol 1993; 84: 61-66.
6. Gratwohl A, Hermans J, Zwaan F. Bone marrow transplantation for AML in Europe. In: Gale RP (ed). Acute Myelogenous Leukemia: Progress and Controversies. Wiley-Liss: New York, 1990, pp 381-390.
7. McGlave PB, Haake RJ, Bostrom BC, Brunning R, Hurd DD, Kim TH, Nesbit ME, Vercellotti GM, Weisdorf D, Wood WG, Ramsay NKC, Kersey JH Allogeneic bone marrow transplantation for acute non lymphocytic leukemia in first remission Blood 1988; 72: 1512-1517.
8. Appelbaum FR, Fisher LD, Thomas ED for the Seattle Marrow Transplant Team. Chemotherapy versus marrow transplantation for adults with acute non-lymphoblastic leukemia: A five year follow-up. Blood 1988; 72: 179-184.
9. Tutschka PJ, Copelan EA, Klein JP. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 1987; 70: 1382-1388.
10. Zittoun RA, Mandelli F, Willemze R, De Witte T, Labar B, Resegotti L, Leoni F, Damasio E, Visani G, Papa G, Caronia F, Hayat M, Stryckmans P, Rotoli B, Leoni P, Peetermans ME, Dardenne M, Vegna ML, Petti MC, Solbu G, Suciu S. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. New Engl J Med 1995; 332: 217-223.
11. Gamberi B, Bandini G, Visani G, Rosti G, Cenacchi A, Motta MR, Fruet F, Calori E, Rizzi S, Tosi P, Belardinelli A, Barbieri E, Conte R, Tura S. Acute myeloid leukemia from diagnosis to bone marrow transplantation: experience from a single centre. Bone Marrow Transplant 1994; 14: 69-72.
12. Gorin NC, Dicke K, Lowenberg B. High dose therapy for acute myelocytic leukemia treatment strategy: what is the choice? Ann Oncol 1993; 4 (Suppl. 1): 59-80.
13. McMillan AK, Goldstone AH, Linch DC, Gribben JG, Patterson KG, Richards JDM, Franklin I, Boughton BJ, Milligan DW, Leyland M, Hutchison RM, Newland AC. High-dose chemotherapy and autologous bone marrow transplantation in acute myeloid leukemia. Blood 1990; 76: 480-488.
14. Chao NJ, Stein AS, Long GD, Negrin RS, Amylon MD, Wong RM, Forman SJ, Blume KG. Busulfan/etoposide - initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute nonlymphoblastic leukemia. Blood 1993; 81: 319-323.
15. Goldstone AH, Anderson CC, Linch DC, Franklin M, Boughton BJ, Cawley JC, Richards JDM. Autologous bone marrow transplantation following high dose chemotherapy for the treatment of adult patients with acute myeloid leukemia. Br J Haematol 1986; 64: 529-537.
16. Meloni G, De Fabritiis P, Carella AM, Mangoni L, Porceilini A, Marmont A, Mandelli F. Autologous bone marrow transplantation in patients with AML in first complete remission. Results of two different conditioning regimens after the same induction and consolidation therapy. Bone Marrow Transplant 1990; 5: 29-32.
17. Cassileth PA, Andersen J, Lazarus HM, Colvin OM, Bennett JM, Stadtmauer EA, Kaizer H, Weiner RS, Edelstein M, Oken MM. Autologous bone marrow transplant in acute myeloid leukemia in first remission. J Clin Oncol 1993; 11: 314-319.
18. Korbling M, Hunstein W, Fliedner TM, Cayeux S, Dörken B, Fehrentz D, Haas R, Ho AD, Keilholz U, Kneuf W, Konig A, Mende U, Pezzuto A, von Reumont J, Wolf GK, Wannenmacher M, zum Winkel K, Rother K. Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemia. Blood 1989; 74: 1898-1904.
19. Yeager AM, Kaizer H, Santos GW, Saral R, Colvin ON, Stuart RK, Brain HG, Burke PJ, Ambinder RF, Burns WH, Fuller DJ, Davis JM, Karp JE, May WS, Rowley SD, Sensenbrenner LL, Vogelsang GB, Wingard JR. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4 hydroperoxycyclophosphamide. New Engl J Med 1986; 315: 141-147.
20. Selvaggi KJ, Wilson JW, Mills LE, Cornwell III GG, Hurd D, Dodge W, Gingrich R, Martin SE, McMillan R, Miller W, Ball ED. Improved outcome for high-risk acute myeloid leukemia patients using autologous bone marrow transplantation and monoclonal antibody-purged bone marrow. Blood 1994; 83: 1698-1705.
21. Gulati S, Acaba L, Yahalom J, Reich L, Motzer R, Crown J, Doherty M, Clarkson B, Berman E, Atzpodien J, Andreeff M, Gee T. Autologous bone marrow transplantation for acute myelogenous leukemia using 4-hydroperoxycyclophosphamide and VP-16 purged bone marrow Bone Marrow Transplant 1992; 10: 129-134.
22. Laporte JP, Douay L, Lopez M, Labopin M, Jouet JP, Lesage S, Stachowiak J, Fouillard L, Isnard F, Noel-Walter MP, Pene F, Deloux J, Van Den Akker J, Grande M, Bauters F, Najman A, Gorin NC. One hundred twenty-five adult patients with primary acute leukemia autografted with marrow purged by mafosfamide: a 10-year single institution experience Blood 1994; 84: 3810-3818.
23. Morrison FS, Kopecky KJ, Head DR, Athens JW, Balcerzak SP, Gumbart C, Dabich L, Costanzi JJ, Coltman CA, Saiki JH, Hussein KK, Fabian CJ, Appelbaum FR. Late intensification with POMP chemotherapy prolongs survival in acute myelogenous leukemia-results of a Southwest Oncology Group Study of Rubidazone versus Adriamicin for remission induction, prophylactic intrathecal therapy, late intensification and Levamisone maintenance. Leukemia 1992; 6: 708-714.
24. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemias. A report of the French-American-British Group. Ann Intern Med 1985; 103: 620-625.
25. Cheson BD, Cassileth PA, Head DR, Schiffer CA, Bennett JM, Bloomfield CD, Brunning R, Gale RP, Grever MR, Keating MJ, Sawitsky A, Stass S, Weinstein H, Woods WG. Report of National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 1990; 8: 813-819.
26. Bozzetti F, La cachessia e la malnutrizione neoplastica. In: Bonadonna G, Robustelli della Cuna G (eds). Manuale di Oncologia Medica, 3rd edn. Masson Editor: Milano, 1990, pp 1023-1038.
27. Kaplan EL, Meier P Non parametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457-481.
28. Peto R, Pike MC, Armitage NE, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Part II. Analysis and examples. Br J Cancer 1977; 35: 1-39.
29. Cox DR. Analysis of Binary Data. Methuen and Co: London, 1970.
30. Cox DR. Regression models and life. Table (with discussion). J R Statist Soc B 1972; 34: 187-220.
31. Mantel N, Byar DP. Evaluation of responce-time data involving transient states: an illustration using heart-transplant data. J Am Stat Assoc 1974; 69: 81-86.
32. Reiffers J, Gaspard MH, Maraninchi D, Michallet M, Marit G, Stoppa AM, Corront B, David B, Gastaut A, Sotto JJ, Broustet A, Carcassonne Y, Hollard D. Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukemia in first remission: a prospective controlled trial. Br J Haematol 1989; 72: 57-63.
33. Reiffers J, Stoppa AM, Attal M, Michallet M, Merit G, Blaise D, Huguet F, Corront B, Cony-Makhoul P, Montastruc M, Gastaut JA, Laurent G, Molina L, Broustet A, Maraninchi D, Pris J, Holland D, Faberes C for BGMT Group. Autologous stem cell transplantation versus chemotherapy for adult patients with acute myeloid leukemia in first remission: the BGMT group experience. Nouv Rev Fr Hematol 1993; 35: 17-19.
34. Cheson BD, Lacerna L, Leyland-Jones B, Sarosy G, Wittes RE: Autologous bone marrow transplantation: current status and future directions. Ann Intern Med 1989; 110: 51-65.
35. Chopra R, Goldstone AH, McMillan AK, Powles R, Smith AG, Prentice HG, Reid C, Marcus R, Bell A, Milligan D, McCarthy D, Morgenstern G, Barnard D. Successful treatment of acute myeloid leukemia beyond first remission with autologous bone marrow transplantation using busulfan/cyclophosphamide and unpurged marrow: The British Autograft Group Experience. J Clin Oncol 1991; 9: 1840-1847.
36. Visani G, Dinota A, Tosi P, Verlicchi F, Motta MR, Rizzi S, Colombini R, Cenacchi A, Fogli M, Lemoli RM, Ricci P, Albertazzi L, Bandini G, Tura S. Cryopreserved autologous bone marrow transplantation in patients with acute nonlymphoid leukemia: chemotherapy before harvesting is the main factor in delaying hematological recovery. Cryobiology 1990; 27: 103-106.
37. Körbling M, Fliedner TM, Holle R, Magrin S, Baumann M, Holdermann E, Eberhardt K. Autologous blood stem cell (ABSCT) versus purged bone marrow transplantation (pAMBT) in standard risk AML: influence of source and cell composition of the autograft on hemopoietic reconstitution and disease-free survival. Bone Marrow Transplant 1991; 7: 343-349
38. Sanz MA, de ta Rubia J, Sanz GF, Martin G, Martinez J, Jarque I, Sempere A, Gomis F, Senent L, Soler MA, Lopez F, Arilla MJ, Carpio N, Guinot M, Palau J, Tudela M, Marty L. Busulfan plus cyclophosphamide followed by autologous blood stem-cell transplantation for patients with acute myeloblastic leukemia in first complete remission: a report from a single Institution. J Clin Oncol 1993; 11: 1661-1667.
39. Frassoni F, Labopin M, Gorin NC. Evolution of allogeneic BMT in Europe: improved results for patients with acute leukemia in first remission. Bone Marrow Transplant 1994; 13 (Suppl): 186 (abstr. 367).
40. Baker F, Wingard JR, Curbow B, Zabora J, Jodrey D, Fogarty L, Legro M. Quality of life of bone marrow transplant long-term survivors. Bone Marrow Transplant 1994; 13: 589-596.